Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Hematologic Neoplasms 2Xerostomia Due to Radiotherapy (Disorder) 1Ulcer 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Seizures 1Renal Insufficiency 1Progressive Metastatic Castrate Resistant Prostate Cancer 1Kidney Failure, Chronic 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Glioma 1Carcinoma, Renal Cell 1COVID-19 1Breast Neoplasms 1Advanced/Metastatic Solid Tumors 12019 Novel Coronavirus 1

Interventions

perampanel 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Seizures × Standard of Care × Clear all
NCT04497142 2024-08-05

Effect of Perampanel on Peritumoral Hyperexcitability in HGG

Dana-Farber Cancer Institute

Phase 1/2 Completed
12 enrolled 8 charts
CNS

Glioma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡